Recombinant SARS-CoV-2 Spike Trimer Protein (aa 16-1213) [His] (CAT#: VReP-124SX)
For Research Use Only. We do not provide direct services or products for patients.
Recombinant SARS-CoV-2 Spike Trimer Protein, expressed from HEK293 Cells with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively.
Used for immunoassays.
Sterile PBS, pH 7.4.
>95% pure by SDS-PAGE.
<1.0 EU/μg by LAL
Store at -20°C to -80°C.
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.